Invokana contains canagliflozin, which lowers blood glucose by preventing glucose reabsorption in the kidneys, allowing excess glucose to be excreted in the urine.
In eligible patients, it also helps reduce the risk of cardiovascular events and slows the progression of diabetic kidney disease when used alongside diet, exercise, and standard therapy.
Uses
- Type 2 diabetes mellitus
- Diabetic kidney disease (when prescribed)
- Cardiovascular risk reduction in eligible patients
Active Ingredient
- Canagliflozin 100mg
How to Take
- Take one tablet once daily before the first meal of the day or as directed by your healthcare provider.
Precautions
- Prescription-only medicine.
- Maintain adequate hydration.
- Monitor kidney function regularly.
- Seek medical attention if symptoms of diabetic ketoacidosis develop.
